Pages that link to "Q34631354"
Jump to navigation
Jump to search
The following pages link to Chronic myeloid leukaemia as a model of disease evolution in human cancer (Q34631354):
Displaying 50 items.
- Expression of the leukemic prognostic marker CD7 is linked to epigenetic modifications in chronic myeloid leukemia (Q21245701) (← links)
- Identification and functional analysis of a new phosphorylation site (Y398) in the SH3 domain of Abi-1 (Q24293171) (← links)
- MUC1-C Oncoprotein Blocks Terminal Differentiation of Chronic Myelogenous Leukemia Cells by a ROS-Mediated Mechanism (Q24626837) (← links)
- Regulation of myeloid leukaemia by the cell-fate determinant Musashi (Q24634359) (← links)
- A new view of carcinogenesis and an alternative approach to cancer therapy (Q24650249) (← links)
- Could Vitamin D Analogues Be Used to Target Leukemia Stem Cells? (Q26747513) (← links)
- The non-genomic loss of function of tumor suppressors: an essential role in the pathogenesis of chronic myeloid leukemia chronic phase (Q26749343) (← links)
- BMI1: A Biomarker of Hematologic Malignancies (Q26750676) (← links)
- Protein Kinase CK2: A Targetable BCR-ABL Partner in Philadelphia Positive Leukemias (Q26769590) (← links)
- Is lineage decision-making restricted during tumoral reprograming of haematopoietic stem cells? (Q26779702) (← links)
- Molecular mechanisms for survival regulation of chronic myeloid leukemia stem cells (Q26828528) (← links)
- JAK2 and genomic instability in the myeloproliferative neoplasms: a case of the chicken or the egg? (Q27012572) (← links)
- Modeling of Chronic Myeloid Leukemia: An Overview of In Vivo Murine and Human Xenograft Models (Q28076328) (← links)
- Molecular pathogenesis of peripheral neuroblastic tumors (Q28271405) (← links)
- Effective killing of Gleevec-resistant CML cells with T315I mutation by a natural compound PEITC through redox-mediated mechanism (Q28275023) (← links)
- Structural resemblances and comparisons of the relative pharmacological properties of imatinib and nilotinib (Q28292463) (← links)
- Quantitative modeling of chronic myeloid leukemia: insights from radiobiology (Q28384954) (← links)
- Hypoxia-inducing factors as master regulators of stemness properties and altered metabolism of cancer- and metastasis-initiating cells (Q28393898) (← links)
- Sustained proliferation in cancer: Mechanisms and novel therapeutic targets (Q28396388) (← links)
- Sex differences in the incidence of chronic myeloid leukemia (Q28396953) (← links)
- Emerging Roles of SIRT1 in Cancer Drug Resistance (Q28536892) (← links)
- ATRA-induced cellular differentiation and CD38 expression inhibits acquisition of BCR-ABL mutations for CML acquired resistance (Q28540033) (← links)
- Evolutionary foundations for cancer biology (Q28709090) (← links)
- TKI rotation-induced persistent deep molecular response in multi-resistant blast crisis of Ph+ CML (Q30357188) (← links)
- miR-328 functions as an RNA decoy to modulate hnRNP E2 regulation of mRNA translation in leukemic blasts (Q30496174) (← links)
- BCR-ABL1 kinase inhibits uracil DNA glycosylase UNG2 to enhance oxidative DNA damage and stimulate genomic instability. (Q30537656) (← links)
- ERK2, but not ERK1, mediates acquired and "de novo" resistance to imatinib mesylate: implication for CML therapy (Q33476874) (← links)
- Reciprocal t(9;22) ABL/BCR fusion proteins: leukemogenic potential and effects on B cell commitment. (Q33513975) (← links)
- Deletions of immunoglobulin heavy chain and T cell receptor gene regions are uniquely associated with lymphoid blast transformation of chronic myeloid leukemia (Q33524890) (← links)
- Emerging drugs for chronic myeloid leukemia (Q33536762) (← links)
- Treatment adherence in chronic myeloid leukaemia patients receiving tyrosine kinase inhibitors (Q33603379) (← links)
- BCR-ABL stimulates mutagenic homologous DNA double-strand break repair via the DNA-end-processing factor CtIP. (Q33727572) (← links)
- Bcr/Abl interferes with the Fanconi anemia/BRCA pathway: implications in the chromosomal instability of chronic myeloid leukemia cells (Q33784347) (← links)
- Generation of iPSCs from cultured human malignant cells (Q33871512) (← links)
- Clonal competition in BcrAbl-driven leukemia: how transplantations can accelerate clonal conversion. (Q33908547) (← links)
- Non random distribution of genomic features in breakpoint regions involved in chronic myeloid leukemia cases with variant t(9;22) or additional chromosomal rearrangements (Q33919931) (← links)
- Methylation status of DDIT3 gene in chronic myeloid leukemia (Q33933648) (← links)
- Pristimerin induces apoptosis in imatinib-resistant chronic myelogenous leukemia cells harboring T315I mutation by blocking NF-kappaB signaling and depleting Bcr-Abl (Q33944952) (← links)
- Bcl2 is not required for the development and maintenance of leukemia stem cells in mice. (Q33947776) (← links)
- Chronic myeloid leukemia: mechanisms of blastic transformation (Q33968037) (← links)
- GTPase regulator associated with the focal adhesion kinase (GRAF) transcript was down-regulated in patients with myeloid malignancies (Q34081636) (← links)
- Destabilization of Bcr-Abl/Jak2 Network by a Jak2/Abl Kinase Inhibitor ON044580 Overcomes Drug Resistance in Blast Crisis Chronic Myelogenous Leukemia (CML) (Q34082540) (← links)
- Regulation of hTERT by BCR-ABL at multiple levels in K562 cells (Q34094028) (← links)
- The B cell mutator AID promotes B lymphoid blast crisis and drug resistance in chronic myeloid leukemia (Q34099472) (← links)
- Predicting relapse prior to transplantation in chronic myeloid leukemia by integrating expert knowledge and expression data (Q34148173) (← links)
- ABCB1 regulation through LRPPRC is influenced by the methylation status of the GC -100 box in its promoter (Q34183433) (← links)
- Dasatinib early intervention after cytogenetic or hematologic resistance to imatinib in patients with chronic myeloid leukemia (Q34251703) (← links)
- 5-aza-2'-deoxycytidine-mediated c-myc Down-regulation triggers telomere-dependent senescence by regulating human telomerase reverse transcriptase in chronic myeloid leukemia (Q34346801) (← links)
- Wnt/β-catenin pathway regulates ABCB1 transcription in chronic myeloid leukemia. (Q34348134) (← links)
- Imaging the intracellular distribution of tyrosine kinase inhibitors in living cells with quantitative hyperspectral stimulated Raman scattering (Q34384711) (← links)